As of 2026-05-27, the EV/EBITDA ratio of Samrat Pharmachem Ltd (530125.BO) is 296.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 530125.BO's latest enterprise value is 724.15 mil INR. 530125.BO's TTM EBITDA according to its financial statements is 2.45 mil INR. Dividing these 2 quantities gives us the above 530125.BO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 9.9x | 9.0x |
| Forward P/E multiples | 6.7x - 8.1x | 6.8x |
| Fair Price | 4.73 - 287.42 | 124.66 |
| Upside | -98.0% - 23.6% | -46.4% |
| Date | EV/EBITDA |
| 2026-05-25 | 298.39 |
| 2026-05-22 | 287.21 |
| 2026-05-21 | 282.73 |
| 2026-05-20 | 265.74 |
| 2026-05-19 | 272.56 |
| 2026-05-18 | 273.70 |
| 2026-05-15 | 272.56 |
| 2026-05-14 | 265.80 |
| 2026-05-13 | 272.37 |
| 2026-05-12 | 276.35 |
| 2026-05-11 | 276.35 |
| 2026-05-08 | 273.89 |
| 2026-05-07 | 282.73 |
| 2026-05-06 | 262.71 |
| 2026-05-05 | 270.98 |
| 2026-05-04 | 271.80 |
| 2026-04-30 | 268.45 |
| 2026-04-29 | 267.76 |
| 2026-04-28 | 269.46 |
| 2026-04-27 | 266.94 |
| 2026-04-24 | 272.62 |
| 2026-04-23 | 281.09 |
| 2026-04-22 | 282.73 |
| 2026-04-21 | 280.20 |
| 2026-04-20 | 278.24 |
| 2026-04-17 | 286.20 |
| 2026-04-16 | 280.14 |
| 2026-04-15 | 273.51 |
| 2026-04-13 | 267.57 |
| 2026-04-10 | 263.91 |
| 2026-04-09 | 268.71 |
| 2026-04-08 | 276.85 |
| 2026-04-07 | 266.31 |
| 2026-04-06 | 268.90 |
| 2026-04-02 | 263.08 |
| 2026-04-01 | 247.61 |
| 2026-03-30 | 245.59 |
| 2026-03-27 | 248.75 |
| 2026-03-25 | 258.79 |
| 2026-03-24 | 254.94 |
| 2026-03-23 | 263.78 |
| 2026-03-20 | 271.86 |
| 2026-03-19 | 266.31 |
| 2026-03-18 | 274.71 |
| 2026-03-17 | 256.83 |
| 2026-03-16 | 262.64 |
| 2026-03-13 | 270.47 |
| 2026-03-12 | 267.51 |
| 2026-03-11 | 290.12 |
| 2026-03-10 | 280.08 |